This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

The Healthy Options Feasibility Study

This study has been completed.
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
Steven Grover, MD, McGill University
ClinicalTrials.gov Identifier:
NCT00746460
First received: September 3, 2008
Last updated: January 10, 2014
Last verified: January 2014
  Purpose
The investigators hypothesize that having health care providers other than physicians within a "Groupe de Médecine de Famille" conduct cardiovascular risk assessments and teach lifestyle interventions to primary prevention patients will increase the likelihood that patients will adopt and maintain healthy lifestyles. These objectives will be supported by providing subjects with a cardiovascular risk profile estimating the subject's risk of cardiovascular disease and teaching them how to use the resources related to lifestyle changes available on the www.myhealthcheckup.com Web site.

Condition Intervention
Obesity Sedentary Lifestyle Dyslipidemia Hypertension Cigarette Smoking Diabetes Behavioral: CVD risk profile

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: The Effectiveness of CVD Risk Profiles When Used by Allied Health Care Providers (HCP) Within a "Groupe de Médecine de Famille": The Healthy Options Feasibility Study.

Further study details as provided by Steven Grover, MD, McGill University:

Primary Outcome Measures:
  • Feasibility of using health care providers other than physicians within a GMF to conduct a CV risk assessment and intervention on primary prevention patients [ Time Frame: 10 months ]

Secondary Outcome Measures:
  • Patient's CV risk factors and overall CV risk [ Time Frame: 16 weeks ]
  • Subject's adherence with lifestyle changes and prescribed medications [ Time Frame: 16 weeks ]
  • Satisfaction of the nurse [ Time Frame: 10 months ]
  • Satisfaction of the patient [ Time Frame: 16 weeks ]

Enrollment: 50
Study Start Date: June 2008
Study Completion Date: October 2009
Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: A
Behavioral
Behavioral: CVD risk profile
Cardiovascular risk assessment and behavioral counselling

  Eligibility

Ages Eligible for Study:   30 Years to 79 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Male or female subjects 30-79 years of age without known cardiovascular disease but with one or more risk factors such as obesity, a sedentary lifestyle, dyslipidemia, hypertension, cigarette smoking, or diabetes
  • Have provided informed consent
  • Recent (past 6 months) fasting lipid profile results in the medical charts

Exclusion Criteria:

  • Unable or unlikely to follow and/or complete study or evidence of uncooperative attitude
  • Subject is not literate in either French or English
  • Subject does not have easy and regular access to the Internet
  • Exercise or weight loss are contra-indicated for medical reasons
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00746460

Locations
Canada, Quebec
McGill Cardiovascular Health Improvement Program
Montreal, Quebec, Canada, H3Z 2A7
Sponsors and Collaborators
McGill University
Pfizer
Investigators
Principal Investigator: Steven Grover, MD McGill Cardiovascualr Health Improvement Program
  More Information

Additional Information:
Responsible Party: Steven Grover, MD, Medical Director McGill Comprehensive Health Improvement Program, McGill University
ClinicalTrials.gov Identifier: NCT00746460     History of Changes
Other Study ID Numbers: CLIN-08001
Study First Received: September 3, 2008
Last Updated: January 10, 2014

Keywords provided by Steven Grover, MD, McGill University:
primary prevention
patient knowledge
nurse
exercise
smoking cessation
weight loss

Additional relevant MeSH terms:
Dyslipidemias
Lipid Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on August 18, 2017